标题
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
作者
关键词
-
出版物
CARDIOVASCULAR RESEARCH
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-06-04
DOI
10.1093/cvr/cvz153
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimising experimental research in respiratory diseases: an ERS statement
- (2018) Philippe Bonniaud et al. EUROPEAN RESPIRATORY JOURNAL
- Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
- (2018) Yuichi Tamura et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
- (2018) Jonathan Florentin et al. JOURNAL OF IMMUNOLOGY
- Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension
- (2018) Morane Le Hiress et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemokine receptor 7 overexpression promotes mesenchymal stem cell migration and proliferation via secreting Chemokine ligand 12
- (2018) Ling Liu et al. Scientific Reports
- Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia
- (2018) Pierre Regenass et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of CXCR7 as a Common Predictor for Prognosis in Solid Tumors: a Meta-Analysis
- (2018) Qitai Zhao et al. Journal of Cancer
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
- (2017) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension
- (2017) Rahul Kumar et al. Nature Communications
- Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
- (2016) Christophe Guignabert et al. JOURNAL OF CLINICAL INVESTIGATION
- Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
- (2015) Morane Le Hiress et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Leptin signalling system as a target for pulmonary arterial hypertension therapy
- (2015) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
- (2015) Takahiro Hashimoto-Kataoka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer
- (2015) Ping Long et al. TUMOR BIOLOGY
- Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
- (2015) Brian N. McCullagh et al. PLoS One
- Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension
- (2014) Alice Huertas et al. CIRCULATION
- Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
- (2014) Nicolas Ricard et al. CIRCULATION
- Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
- (2014) Marlene Rabinovitch et al. CIRCULATION RESEARCH
- Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension
- (2014) Tao Yang et al. HEART & LUNG
- CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit+ Cells in Rats
- (2014) Daniela Farkas et al. PLoS One
- An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice
- (2013) François Daubeuf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
- (2013) W. Tian et al. Science Translational Medicine
- A Critical Role for p130Casin the Progression of Pulmonary Hypertension in Humans and Rodents
- (2012) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of chemokine receptor CXCR7 in bladder cancer progression
- (2012) Mingang Hao et al. BIOCHEMICAL PHARMACOLOGY
- Antagonism of CXCR7 attenuates chronic hypoxia–induced pulmonary hypertension
- (2012) Ecaterina Sartina et al. PEDIATRIC RESEARCH
- C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension
- (2011) David Montani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
- (2011) S. Farha et al. BLOOD
- A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease
- (2011) Christine M. Costello et al. EUROPEAN RESPIRATORY JOURNAL
- Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells
- (2011) A Dar et al. LEUKEMIA
- Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo
- (2011) Vincent Gasparik et al. ACS Medicinal Chemistry Letters
- Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
- (2010) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
- (2010) N. Gambaryan et al. EUROPEAN RESPIRATORY JOURNAL
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension
- (2009) Karen C. Young et al. CIRCULATION RESEARCH
- Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
- (2009) S. K. Martin et al. HAEMATOLOGICA
- c/EBPβ Is a Major Regulatory Element Driving Transcriptional Activation of the CXCL12 Promoter
- (2009) E. Calonge et al. JOURNAL OF MOLECULAR BIOLOGY
- Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice
- (2008) Han Gerrits et al. GENESIS
- Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
- (2008) Muriel Hachet-Haas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis
- (2008) Meizhang Li et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started